• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期糖基化终末产物戊糖苷与类风湿关节炎中的白细胞介素-6及其他相关炎症标志物相关。

The advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis.

作者信息

Hein Gert E, Köhler Markus, Oelzner Peter, Stein Günter, Franke Sybille

机构信息

Rheumatology and Osteology, Department of Internal Medicine III, Friedrich Schiller University of Jena, 07740 Jena, Germany.

出版信息

Rheumatol Int. 2005 Dec;26(2):137-41. doi: 10.1007/s00296-004-0518-1. Epub 2004 Dec 3.

DOI:10.1007/s00296-004-0518-1
PMID:15580352
Abstract

OBJECTIVE

Oxidative stress and inflammatory processes accelerate the formation of advanced glycation end products (AGE), e.g. of pentosidine. The aim of this study was to investigate the relationships between levels of pentosidine in serum and synovial fluid, proinflammatory cytokines, other markers of inflammatory activity, and the state of radiologically visible bone destruction in patients with rheumatoid arthritis (RA).

OBJECTIVES

One hundred thirty-three nondiabetic RA patients and 56 age-matched, healthy subjects were included. Serum and synovial fluid pentosidine, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and rheumatoid factor levels were determined. In 30 patients, the proinflammatory cytokines interleukin (IL)-1beta, IL-6, and TNF-alpha and the soluble receptors sIL-2R, sIL-6R, sTNF-alpha, and RI/RII were also measured.

RESULTS

Serum levels of pentosidine were on average significantly higher in RA patients than in healthy subjects and correlated significantly to ESR, CRP, and serum levels of IL-6. Serum and synovial fluid pentosidine did not show any differences. Rheumatoid factor-positive RA patients had higher pentosidine levels in the synovial fluid than rheumatoid factor-negative patients. Correlations could not be found between pentosidine and the other cytokines or cytokine receptors measured.

CONCLUSION

The binding of AGE on cell receptors induces activation of nuclear factor kappa B, resulting in enhanced synthesis of proinflammatory cytokines. Moreover, AGE generation may also lead to the formation of new, immunologically relevant epitopes at synovial proteins. Both mechanisms could contribute to initiation and perpetuation of the inflammatory and destructive processes in RA.

摘要

目的

氧化应激和炎症过程会加速晚期糖基化终产物(AGE)的形成,例如戊糖苷。本研究的目的是调查类风湿关节炎(RA)患者血清和滑液中戊糖苷水平、促炎细胞因子、炎症活动的其他标志物以及放射学可见骨破坏状态之间的关系。

对象

纳入133例非糖尿病RA患者和56例年龄匹配的健康受试者。测定血清和滑液中的戊糖苷、红细胞沉降率(ESR)、C反应蛋白(CRP)和类风湿因子水平。在30例患者中,还检测了促炎细胞因子白细胞介素(IL)-1β、IL-6和肿瘤坏死因子-α以及可溶性受体sIL-2R、sIL-6R、sTNF-α和RI/RII。

结果

RA患者血清中戊糖苷水平平均显著高于健康受试者,且与ESR、CRP和IL-6血清水平显著相关。血清和滑液中的戊糖苷无差异。类风湿因子阳性的RA患者滑液中戊糖苷水平高于类风湿因子阴性患者。未发现戊糖苷与所检测的其他细胞因子或细胞因子受体之间存在相关性。

结论

AGE与细胞受体结合可诱导核因子κB活化,导致促炎细胞因子合成增加。此外,AGE的产生还可能导致滑膜蛋白上新的免疫相关表位形成。这两种机制都可能有助于RA炎症和破坏过程的启动和持续。

相似文献

1
The advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis.晚期糖基化终末产物戊糖苷与类风湿关节炎中的白细胞介素-6及其他相关炎症标志物相关。
Rheumatol Int. 2005 Dec;26(2):137-41. doi: 10.1007/s00296-004-0518-1. Epub 2004 Dec 3.
2
Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers.类风湿关节炎患者血浆和滑液中晚期糖基化终产物戊糖苷的增加及其与炎症标志物的关系。
Biochem Biophys Res Commun. 1998 Mar 6;244(1):45-9. doi: 10.1006/bbrc.1998.8203.
3
Comparison of the concentrations of pentosidine in the synovial fluid, serum and urine of patients with rheumatoid arthritis and osteoarthritis.类风湿关节炎和骨关节炎患者滑液、血清及尿液中戊糖苷浓度的比较。
Rheumatology (Oxford). 1999 Dec;38(12):1275-8. doi: 10.1093/rheumatology/38.12.1275.
4
Advanced glycation end-product pentosidine is not a relevant marker of disease activity in patients with rheumatoid arthritis.晚期糖基化终产物戊糖苷不是类风湿关节炎患者疾病活动的相关标志物。
Physiol Res. 2007;56(6):771-777. doi: 10.33549/physiolres.931147. Epub 2007 Feb 8.
5
Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein.膝骨关节炎患者血清和滑液中晚期糖基化终产物戊糖苷含量增加及其与软骨寡聚基质蛋白的关系
Ann Rheum Dis. 2005 Jun;64(6):886-90. doi: 10.1136/ard.2004.029140.
6
Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis.骨关节炎和类风湿关节炎滑液中的戊糖苷:与类风湿关节炎疾病活动的关系。
J Rheumatol. 1998 Dec;25(12):2440-4.
7
Relationship between pentosidine levels in serum and urine and activity in rheumatoid arthritis.血清和尿液中戊糖苷水平与类风湿关节炎活动度之间的关系。
Br J Rheumatol. 1997 Jun;36(6):637-42. doi: 10.1093/rheumatology/36.6.637.
8
Interleukin-6, soluble interleukin-2 receptor and soluble interleukin-6 receptor in the sera of patients with different histological patterns of rheumatoid synovitis.不同组织学类型类风湿性滑膜炎患者血清中的白细胞介素-6、可溶性白细胞介素-2受体和可溶性白细胞介素-6受体
Clin Exp Rheumatol. 2003 Jan-Feb;21(1):63-9.
9
Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies.不同关节病患者血清和滑液中可溶性白细胞介素6(IL-6)受体及IL-6水平
J Rheumatol. 1997 Nov;24(11):2069-75.
10
Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.类风湿关节炎、反应性关节炎和骨关节炎患者血清及滑液中肿瘤坏死因子和白细胞介素-2的可溶性受体
J Rheumatol. 1995 Mar;22(3):406-12.

引用本文的文献

1
The Potential Influence of Advanced Glycation End Products and (s)RAGE in Rheumatic Diseases.晚期糖基化终产物及其受体(sRAGE)在风湿性疾病中的潜在影响。
Int J Mol Sci. 2023 Feb 2;24(3):2894. doi: 10.3390/ijms24032894.
2
Dietary advanced glycation end-products elicit toxicological effects by disrupting gut microbiome and immune homeostasis.饮食中晚期糖基化终产物通过破坏肠道微生物组和免疫稳态引发毒理学效应。
J Immunotoxicol. 2021 Jul 24;18(1):93-104. doi: 10.1080/1547691X.2021.1959677.
3
Plasma pentosidine levels are associated with prevalent fractures in patients with chronic liver disease.

本文引用的文献

1
Identification of the receptor for advanced glycation end products in synovial tissue of patients with rheumatoid arthritis.类风湿关节炎患者滑膜组织中晚期糖基化终末产物受体的鉴定。
Rheumatol Int. 2005 Aug;25(6):411-3. doi: 10.1007/s00296-004-0456-y. Epub 2004 Mar 26.
2
Advanced glycation end-products pentosidine and N epsilon-carboxymethyllysine are elevated in serum of patients with osteoporosis.晚期糖基化终末产物戊糖苷和N-ε-羧甲基赖氨酸在骨质疏松症患者血清中升高。
Rheumatology (Oxford). 2003 Oct;42(10):1242-6. doi: 10.1093/rheumatology/keg324. Epub 2003 May 30.
3
Are advanced glycation end-product-modified proteins of pathogenetic importance in fibromyalgia?
血浆戊糖素水平与慢性肝病患者的骨折患病率相关。
PLoS One. 2021 Apr 2;16(4):e0249728. doi: 10.1371/journal.pone.0249728. eCollection 2021.
4
MicroRNA-181c Inhibits Interleukin-6-mediated Beta Cell Apoptosis by Targeting TNF-α Expression.微小 RNA-181c 通过靶向 TNF-α 表达抑制白细胞介素-6 介导的胰岛β细胞凋亡。
Molecules. 2019 Apr 10;24(7):1410. doi: 10.3390/molecules24071410.
5
Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection.托珠单抗治疗类风湿关节炎:基于证据的综述与患者选择
Drug Des Devel Ther. 2018 Dec 19;13:57-70. doi: 10.2147/DDDT.S150580. eCollection 2019.
6
Tumor necrosis factor receptor 2 as a possible marker of COPD in smokers and ex-smokers.肿瘤坏死因子受体2作为吸烟者和既往吸烟者慢性阻塞性肺疾病的一种可能标志物。
Int J Chron Obstruct Pulmon Dis. 2017 Jul 7;12:2015-2021. doi: 10.2147/COPD.S138558. eCollection 2017.
7
Profile of sarilumab and its potential in the treatment of rheumatoid arthritis.托珠单抗简介及其在类风湿关节炎治疗中的潜力。
Drug Des Devel Ther. 2017 May 24;11:1593-1603. doi: 10.2147/DDDT.S100302. eCollection 2017.
8
Protective effect of taraxasterol against rheumatoid arthritis by the modulation of inflammatory responses in mice.蒲公英甾醇通过调节小鼠炎症反应对类风湿性关节炎的保护作用。
Exp Ther Med. 2016 Dec;12(6):4035-4040. doi: 10.3892/etm.2016.3860. Epub 2016 Nov 2.
9
Serum and bone pentosidine in patients with low impact hip fractures and in patients with advanced osteoarthritis.低暴力性髋部骨折患者和晚期骨关节炎患者的血清及骨戊糖苷
BMC Musculoskelet Disord. 2016 Jul 22;17:308. doi: 10.1186/s12891-016-1168-7.
10
Possible rheumatoid arthritis subtypes in terms of rheumatoid factor, depression, diagnostic delay and emotional expression: an exploratory case-control study.根据类风湿因子、抑郁、诊断延迟和情绪表达划分的可能的类风湿关节炎亚型:一项探索性病例对照研究
Arthritis Res Ther. 2013 Mar 21;15(2):R45. doi: 10.1186/ar4204.
晚期糖基化终产物修饰的蛋白质在纤维肌痛中具有致病重要性吗?
Rheumatology (Oxford). 2002 Oct;41(10):1163-7. doi: 10.1093/rheumatology/41.10.1163.
4
Identification of the advanced glycation end products N(epsilon)-carboxymethyllysine in the synovial tissue of patients with rheumatoid arthritis.类风湿关节炎患者滑膜组织中晚期糖基化终末产物N(ε)-羧甲基赖氨酸的鉴定。
Ann Rheum Dis. 2002 Jun;61(6):488-92. doi: 10.1136/ard.61.6.488.
5
Diabetes and advanced glycation endproducts.糖尿病与晚期糖基化终末产物
J Intern Med. 2002 Feb;251(2):87-101. doi: 10.1046/j.1365-2796.2002.00932.x.
6
The AGE-receptor in the pathogenesis of diabetic complications.晚期糖基化终末产物受体在糖尿病并发症发病机制中的作用
Diabetes Metab Res Rev. 2001 Nov-Dec;17(6):436-43. doi: 10.1002/dmrr.233.
7
Advanced glycation endproducts: activators of cardiac remodeling in primary fibroblasts from adult rat hearts.晚期糖基化终产物:成年大鼠心脏原代成纤维细胞中心脏重塑的激活剂。
Mol Med. 2001 Aug;7(8):543-51.
8
Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology.核因子-κB 受体激活剂配体和骨保护素在骨细胞生物学中的作用。
J Mol Med (Berl). 2001 Jun;79(5-6):243-53. doi: 10.1007/s001090100226.
9
NF-kappa B in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction.类风湿关节炎中的核因子κB:炎症、增生及组织破坏的关键调节因子
Arthritis Res. 2001;3(4):200-6. doi: 10.1186/ar300. Epub 2001 Mar 26.
10
The role of osteoprotegerin and receptor activator of nuclear factor kappaB ligand in the pathogenesis and treatment of rheumatoid arthritis.
Arthritis Rheum. 2001 Feb;44(2):253-9. doi: 10.1002/1529-0131(200102)44:2<253::AID-ANR41>3.0.CO;2-S.